Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9931189 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery
Condition: Cardiovascular Disease
Intervention: Drug: Hemolink (hemoglobin raffimer IV solution)

Study has passed its completion date and status has not been verified in more than two years.